Nitto Denko Avecia, Inc. a provider of oligonucleotide API manufacturing, has opened a new corporate office in Cambridge, MA, to support its operations and corporate development activities, and to be more accessible to clients.

Detlef Rethage, president of Avecia said, “The new office, located in Kendall Square, the hotspot for oligonucleotides-based therapeutics, brings Avecia, its subsidiary Nitto Avecia Pharma Services, and all other Nitto Life Sciences activities closer to its existing partners in the US. This is just another step the organization is taking in support of Nitto’s corporate credo, ‘NITTO EVERYWHERE’.”

Nitto Avecia, Inc. has facilities in Milford, MA, Marlboro, MA, and Cincinnati, OH offering services for DNA, RNA and other oligonucleotides-based therapeutics from milligram scale at preclinical stage to 1000kg + post commercial launch.